The hybrid nanoparticles target tumors effectively, overcoming common drug resistance mechanisms by inhibiting the PI3K/AKT/mTOR pathway, generating ROS, and depleting glutathione (GSH), leading to enhanced cancer cell apoptosis. Here, AKT1 is linked to cancer.